Oligodendrocyte pathophysiology: a new view of schizophrenia.
暂无分享,去创建一个
[1] J. Roder,et al. Myelination in the absence of myelin-associated glycoprotein , 1994, Nature.
[2] D. Kirschner,et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. , 1994, Neuron.
[3] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[4] P. Goldman-Rakic,et al. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.
[5] S. Potkin,et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[6] R. Miledi,et al. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Goldman-Rakic,et al. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.
[8] P. Goldman-Rakic,et al. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three‐dimensional, stereologic counting method , 1998, The Journal of comparative neurology.
[9] S. Hirsch,et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[10] J. Mcdonald,et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.
[11] E. Bongarzone,et al. Identification of the Dopamine D3 Receptor in Oligodendrocyte Precursors: Potential Role in Regulating Differentiation and Myelin Formation , 1998, The Journal of Neuroscience.
[12] M S Buchsbaum,et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia , 1998, Neuroreport.
[13] A. D. de Crespigny,et al. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. , 1999, Archives of general psychiatry.
[14] P. Goldman-Rakic,et al. The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.
[15] P. Somogyi,et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.
[16] P. Kalus,et al. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients , 2000, Neuroreport.
[17] G J Barker,et al. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[18] R. Conley,et al. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.
[19] D. Lewis,et al. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.
[20] Pat Levitt,et al. Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.
[21] R. Quarles,et al. Oligodendrocytes in aging mice lacking myelin‐associated glycoprotein are dystrophic but not apoptotic , 2000, Journal of neuroscience research.
[22] Richard Reynolds,et al. The oligodendrocyte precursor cell in health and disease , 2001, Trends in Neurosciences.
[23] A. Sampson,et al. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.
[24] M. Weiss,et al. Nerve conduction abnormalities in aging mice deficient for myelin‐associated glycoprotein , 2001, Muscle & nerve.
[25] W H Wong,et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] G J Barker,et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. , 2001, Brain : a journal of neurology.
[27] V. Haroutunian,et al. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. , 2001, The American journal of psychiatry.
[28] N. Uranova,et al. Electron microscopy of oligodendroglia in severe mental illness , 2001, Brain Research Bulletin.
[29] Ravi S. Menon,et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.
[30] K. Nave,et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.
[31] J. Breeze,et al. Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study , 2003, Neuroreport.
[32] R. Kikinis,et al. Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study , 2003, Biological Psychiatry.
[33] Philip D. Harvey,et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.
[34] J. Morrison,et al. Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. , 2003, Cerebral cortex.
[35] Patrick R Hof,et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.
[36] Peter B. Jones,et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.
[37] C. L. Barr,et al. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia , 2003, Schizophrenia Research.
[38] Nora I. Perrone-Bizzozero,et al. Altered Myelination of the Hippocampal Formation in Subjects with Schizophrenia and Bipolar Disorder , 2004, Neurochemical Research.
[39] L. Gelbert,et al. Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia , 2004, Neurobiology of Disease.
[40] Zhiguo Sun,et al. Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. , 2004, The American journal of psychiatry.
[41] A. Kakita,et al. Prefrontal Abnormality of Schizophrenia Revealed by DNA Microarray: Impact on Glial and Neurotrophic Gene Expression , 2004, Annals of the New York Academy of Sciences.
[42] K. Blennow,et al. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study , 2004, Biological Psychiatry.
[43] T. Crawford,et al. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: Neuropathology and behavioral deficits in single- and double-null mice , 2005, Experimental Neurology.
[44] Vahram Haroutunian,et al. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.
[45] Lin He,et al. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population , 2005, Neuroscience Letters.
[46] Kazuo Yamada,et al. DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia , 2005, The Journal of Neuroscience.
[47] Lin He,et al. A family-based association study of the MOG gene with schizophrenia in the Chinese population , 2005, Schizophrenia Research.
[48] Carl-Fredrik Westin,et al. DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity , 2005, NeuroImage.
[49] S. Skaper,et al. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation , 2005, Glia.
[50] C. Aston,et al. Original Research Article , 2004 .
[51] C. Matute. Oligodendrocyte NMDA receptors: a novel therapeutic target. , 2006, Trends in molecular medicine.
[52] Kazuo Yamada,et al. A family‐based and case‐control association study of SOX10 in schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[53] N. Jareborg,et al. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] C. Konradi,et al. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. , 2006, Bipolar disorders.
[55] Michael J Owen,et al. Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. , 2006, Archives of general psychiatry.
[56] Stella Dracheva,et al. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients , 2006, Neurobiology of Disease.
[57] M. Buchsbaum,et al. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus , 2006, Schizophrenia Research.
[58] L. A. McInnes,et al. RNA metabolism and dysmyelination in schizophrenia , 2006, Neuroscience & Biobehavioral Reviews.